Erasca to Present at the Bank of America Securities Health Care Conference

Core Viewpoint - Erasca, Inc. is actively participating in the Bank of America Securities 2025 Health Care Conference, highlighting its focus on precision oncology for RAS/MAPK pathway-driven cancers [1]. Company Overview - Erasca, Inc. is a clinical-stage precision oncology company dedicated to discovering, developing, and commercializing therapies specifically for patients with RAS/MAPK pathway-driven cancers [3]. - The company was co-founded by pioneers in precision oncology and RAS targeting, aiming to create novel therapies and combination regimens to effectively shut down the RAS/MAPK pathway [3]. - Erasca has developed one of the most comprehensive pipelines focused on the RAS/MAPK pathway in the industry, supported by a scientific advisory board of leading experts [3]. Event Participation - Management will present at the conference on May 14, 2025, at 2:35 pm Pacific Time and will engage in one-on-one investor meetings [1]. - A live audio webcast of the event will be available on Erasca's website, with an archived replay accessible for 30 days post-event [2].